Pharmacyclicsan Abbvie Companyis A Biopharmaceutical Subsidiary Focused On Developing Therapies For Oncology And Immune Mediated Diseasesfounded In 1991 And Headquartered In Sunnyvalecaliforniait Became Part Of Abbvie In 2015The Company Aims To Address Unmet Medical Needs In Cancer Treatmentenhancing The Quality And Duration Of Life For Patients Pharmacyclics Operates Within Abbvieae S Oncology Divisionwhich Includes Three Marketed Products And A Robust Pipeline With Over 200 Clinical Trials For More Than 20 Cancer Typesthe Company Utilizes Advanced Technologies Such As Bispecific Antibodiesantibody Drug Conjugatesand Covalent Inhibitor Platforms To Create Targeted Therapies For Hematologic Malignancies And Solid Tumorsits Efforts Are Directed Towards Healthcare Providersoncologistsand Patients Dealing With Various Cancersincluding Leukemia And Lymphoma
No conferences found for this company.
| Company Name | Pharmacyclics Switzerland Gmbh |
| Country |
Switzerland
|
| Address | N/A |
| Telephone | N/A |
| N/A |
